Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-17-059720
Filing Date
2017-11-16
Accepted
2017-11-16 16:18:49
Documents
2
Group Members
BAKER BROS. ADVISORS (GP) LLCFELIX J. BAKERJULIAN C. BAKER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tv479759_sc13d.htm SC 13D 93166
2 EXHIBIT 99.1 tv479759_ex99-1.htm EX-99.1 5614
  Complete submission text file 0001144204-17-059720.txt   100568
Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

EIN.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 60 AVENUE ROCKEFELLER LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Subject) CIK: 0001624422 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90180 | Film No.: 171208233
SIC: 2836 Biological Products, (No Diagnostic Substances)